Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Use of psychotropic medications in Sao Paulo Metropolitan Area, Brazil: pattern of healthcare provision to general population

Texto completo
Autor(es):
Campanha, Angela Maria [1, 2] ; Siu, Erica Rosanna [1] ; Milhoranca, Igor Andre [3] ; Viana, Maria Carmen [4] ; Wang, Yuan-Pang [1] ; Andrade, Laura Helena [1]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Sect Psychiat Epidemiol LIM 23, BR-05403010 Sao Paulo, SP - Brazil
[2] Univ Estadual Maringa, Dept Pharm, Maringa, PR - Brazil
[3] Univ Sao Paulo, Inst Math & Stat, BR-05403010 Sao Paulo, SP - Brazil
[4] Univ Fed Espirito Santo, Hlth Sci Ctr, Dept Social Med, Vitoria, ES - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY; v. 24, n. 11, p. 1207-1214, NOV 2015.
Citações Web of Science: 5
Resumo

Purpose We estimate the proportion of psychotropic medication use (PMU) among adults in Sao Paulo Metropolitan Area, Brazil. We investigated whether socio-demographic factors, comorbidity, and disease severity influence PMU among individuals with psychiatric disorders. Methods Data are from the Sao Paulo Megacity Mental Health Survey, a cross-sectional, population-based study, the Brazilian branch of the World Mental Health Survey Initiative. Trained lay interviewers face-to-face assessed psychiatric disorders and PMU through the Composite International Diagnostic Interview. Respondents were asked about use of healthcare service and prescribed medications for mental disorders in the previous year. Information on PMU was collected for 2935 adult residents in the area and among those with disorders who received treatment. Results Around 6% of respondents reported PMU in the past year: hypnotics or sedatives were used by 3.7% and antidepressants by 3.5%. Among individuals with 12-month disorders, only 14% reported past year PMU. Gender, age, education, income, occupational status, comorbidity, and severity were significant predictors for PMU. Among those with 12-month DSM-IV disorders who obtained treatment in healthcare settings, almost 40% received medication only. Among those treated in specialty mental health service, around 23% received combination of medication and psychotherapy. Conclusion Our study has pointed out that the recent trend of access to mental healthcare in Brazil depicts unmet needs, characterized by a low prevalence of PMU among individuals with psychiatric disorders. Policies that improve appropriate access to prescribed drugs for those most in need are urgent public health priority. Copyright (C) 2015 John Wiley \& Sons, Ltd. (AU)

Processo FAPESP: 03/00204-3 - Estudo epidemiológico dos transtornos psiquiátricos na região metropolitana de São Paulo: prevalências, fatores de risco e sobrecarga social e econômica
Beneficiário:Laura Helena Silveira Guerra de Andrade Burdmann
Linha de fomento: Auxílio à Pesquisa - Temático